Review article: the global emergence of Helicobacter pylori antibiotic resistance
Alimentary Pharmacology & Therapeutics2015Vol. 43(4), pp. 514–533
Citations Over TimeTop 1% of 2015 papers
Irene Thung, Hermineh Aramin, Vera Vavinskaya, Shivi Gupta, Jason Y. Park, Sheila E. Crowe, Mark A. Valasek
Abstract
Since the choice of empiric therapies should be predicated on accurate information regarding antibiotic resistance rates, there is a critical need for determination of current rates at a local scale, and perhaps in individual patients. Such information would not only guide selection of appropriate empiric antibiotic therapy but also inform the development of better methods to identify H. pylori antibiotic resistance at diagnosis. Patient-specific tailoring of effective antibiotic treatment strategies may lead to reduced treatment failures and less antibiotic resistance.
Related Papers
- → Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin‐based therapy in Taiwan(2009)73 cited
- → Variability in Prevalence ofHelicobacter pyloriStrains Resistant to Clarithromycin and Levofloxacin in Southern Poland(2012)23 cited
- → Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? authors’ reply(2010)14 cited
- → Levofloxacin‐based Helicobacter pylori eradication in chronic dyspepsia(2021)5 cited
- → High Levels of Resistance to Metronidazole and Clarithromycin in Helicobacter pylori Strains in Children(2001)73 cited